Biography

Nirav Mehta is a Managing Director of Morgan Stanley and serves as Co-Head of Morgan Stanley Private Equity Asia ex-China, where he leads strategic investments across India and other Asian markets, excluding China. Mr. Mehta has over 19 years of industry experience. Since joining the firm in 2009, he has played an instrumental role in establishing and developing the firm’s India private equity franchise. He led key investments in Clearmedi, Fullife Healthcare, Jana Small Finance, Maiva Pharma, Nspira, RG Stone, Ummeed Housing and ZCL Chemicals.

Mr Mehta currently serves on the board of Clearmedi Healthcare, Fullife Healthcare, Jana Capital, Maiva Pharma, RG Stone and Umeed Housing. Mr. Mehta also serves on the National PE/VC committee of the Confederation of Indian Industries, which advocates for the growth and development of the private equity and venture capital sectors in India. 

Prior to joining Morgan Stanley, Mr. Mehta worked for three years at ICICI Venture, where he focused on growth and buyout transactions across multiple sectors. Mr. Mehta is a native of India and is based in Mumbai. Mr. Mehta received his bachelor’s degree in commerce from St. Xavier’s College and holds an M.B.A. from Indian Institute of Management Bangalore.

 
 
Nirav is a member of the Morgan Stanley Private Equity Asia
 
 
 

May not represent all Team Members.

The information on this page is for informational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.

All investing involves risks, including a loss of principal. Alternative investments are speculative and involve a high degree of risk. These investments are designed for investors who understand and are willing to accept these risks. Performance may be volatile, and an investor could lose all or a substantial portion of his or her investment.

Please refer to the strategy detail page for important information on the strategy, including additional risk considerations.

 

Morgan Stanley Investment Management (Australia) Pty Limited operates under AFSL No: 314182.

Not to be shown, quoted or distributed to the public. The information shown in this website is not personal advice and does not take into account the investment objectives, financial situation or needs of any person.

Information on this website should not be considered a solicitation to buy, an offer to sell or a recommendation for any security in any jurisdiction where such an offer, solicitation or recommendation would be unlawful or unauthorized. In addition, investments may not be made via this website.

Past performance of any product described on this site is not a reliable indication of future performance.


Subscriptions    •    Privacy & Cookies    •    Your Privacy Choices Your Privacy Choices Icon    •    Terms of Use

©  Morgan Stanley | Investment Management (Australia) Pty Limited ACN 122040037